Unlocking the Power of Accesswire: A Must-Read Article for Bloggers and Readers

American Potash Corp. Successfully Closes Private Placement Vancouver, BC / ACCESSWIRE / September 16, 2024 American Potash Corp. (“American Potash”or the”Company”) (CSE:KCL)(OTC PINK:APCOF)(FRA:2P3) has announced the successful closing of the second and final tranche of its non-brokered private placement, raising a total of $1,023,000. The Company issued 4,300,000 units at a price of $0.05 per…

Read More

Maximizing Success: A Professional, Educated, and Profit-Focused Approach to Blogging – AccessWire Article

Pharma-Bio Serv Announces Decrease in Revenues for 2024 Overview Pharma-Bio Serv, Inc. recently announced a decrease in revenues for the three and nine months ended July 31, 2024. The company reported revenues of approximately $2.4 million and $7.2 million for the respective periods, marking a significant decrease compared to the same periods last year. Financial…

Read More

Unlocking the Potential: Relay Therapeutics’ RLY-2608 Data Paves the Way for Program Expansion

Exciting Developments in Breast Cancer Treatment Relay Therapeutics, Inc. recently shared positive interim data from its phase 1 ReDiscover study, which focused on the use of RLY-2608 in combination with fulvestrant to treat PI3Ka-mutated HR+/HER2- locally advanced or metastatic breast cancer patients. This news marks a significant step forward in the fight against this deadly…

Read More

ROSEN Top-Ranked Investor Counsel Urges Agenus Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action (AGEN)

Rosen Law Firm Announces Class Action Lawsuit Against Agenus Inc. New York, Sept. 16, 2024 (GLOBE NEWSWIRE) Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Agenus Inc. (NASDAQ: AGEN) between January 23, 2023 and July 17, 2024, both dates…

Read More

From IPO to Shareholder Success: DSS Inc. Cheers on Impact BioMedical Inc.’s Big Win!

Exciting News in the Biomedical Industry! NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) — DSS, Inc. (NYSE American: DSS), a dedicated supporter and investor in Impact BioMedical Inc. (NYSE American: IBO), is delighted to announce the successful pricing of Impact BioMedical’s initial public offering (IPO). Impact BioMedical, a trailblazer in advancing human healthcare and wellness…

Read More

Unlocking the Power of Accesswire: A Must-Read Article for Bloggers and Readers

TechPrecision Corporation Reports Backlog Increased to $50 Million Customer Confidence Remains High as Fourth Quarter and Fiscal Year Results Released WESTMINSTER, MA / ACCESSWIRE / September 16, 2024 TechPrecision Corporation, a leading manufacturer of precision metal components and systems for the defense and precision industrial sectors, announced today that its backlog has increased to $50…

Read More